Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · IDEX (IEX)

IDEX adds two directors, Disher and Glastra, as Parry and Satterthwaite plan to retire

Neutral Impact 3 of 5 leadership Written later

IDEX Corporation appointed Stephanie Disher and Matthijs Glastra to its Board of Directors, effective February 21, 2025, expanding the Board from 10 to 12 directors. Directors David C. Parry and Livingston L. Satterthwaite will retire after the 2025 Annual Meeting of Stockholders and will not stand for re-election, reducing the Board to 10 seats at that point.

Key points

  • Stephanie Disher joins the Board effective February 21, 2025 and will serve on the Nominating and Corporate Governance Committee.
  • Matthijs Glastra joins the Board effective February 21, 2025 and will serve on the Audit Committee.
  • David C. Parry and Livingston L. Satterthwaite will retire following the 2025 Annual Meeting of Stockholders.
  • Disher is CEO of Atmus Filtration Technologies and Glastra is Chair and CEO of Novanta Inc.

The filing

CompanyIDEX (IEX)
Form8-K, current report
Filed with the SECFeb 20, 2025, 4:32 PM ET
Accession number0000832101-25-000011

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:11 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.